Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Change-Receivables" stands at -58.12 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.
Sumitomo Dainippon Pharma Co Ltd's second quarter result of -32.45 Billion JPY for the item "Change Receivables" represents a decrease of -176.93 percent compared to it's first quarter result.
Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of -32.45 Billion JPY for the item "Change Receivables" represents a decrease of -2,015.82 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of -58.12 Billion JPY for the item "Change Receivables" represents a decrease of -142.46 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -86.67 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -86.67 Billion Japanese Yens.
The 3 year change is -79.03 Billion Japanese Yens.
The 5 year change is -37.03 Billion Japanese Yens.
The 10 year change is -71.13 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |